A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities

Human epidermal growth factor receptor 2 (HER2) is overexpressed in approximately 20% to 30% of breast cancers and various other types of cancers, which plays a vital role in the cancer progression. Monoclonal antibodies targeting Her2 are now used in the clinic to treat Her2 overexpression cancer p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Oncol
Main Authors: Wu, Xiaoqiong, Chen, Siqi, Lin, Limin, Liu, Jiayu, Wang, Yanlan, Li, Yumei, Li, Qing, Wang, Zhong
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2018
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5852409/
https://ncbi.nlm.nih.gov/pubmed/29455083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.01.024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados